Silicon Investor (SI) -- The First Internet Community

STOCKTALK

We've detected that you're using an ad content blocking browser plug-in or feature. Ads provide a critical source of revenue to the continued operation of Silicon Investor. We ask that you disable ad blocking while on Silicon Investor in the best interests of our community. If you are not using an ad blocker but are still receiving this message, make sure your browser's tracking protection is set to the 'standard' level.

Politics : Ask Michael Burke -- Ignore unavailable to you. Want to Upgrade?

To: Les H who wrote (75997)	2/16/2000 3:54:00 PM
From: Thomas M.	Read Replies (2) \| Respond to of 132070

"The Quote" Broker: To sell, or not to sell- that is the question: Whether 'tis nobler in the mind to suffer The slings and arrows of outrageous timing Or to place a stop loss against a sea of troubles, And by opposing end them. Client: Uh, I only wanted a stock quote.

To: Les H who wrote (75997)	2/16/2000 7:37:00 PM
From: Zeev Hed	Respond to of 132070

Les, I never heard of "preliminary" patents, the PTO introduced about two years ago the "Provisional" patent, but apart of giving patent lawyers a second go at corporate purses, there is very little usefulness in these either. If a company is "religious " about documenting the time of the invention (even with a document sent to the PTO under the "disclosure document program"), that is all they need to prove the "first to invent" status, which in the US is still the law. In Europe and Japan they moved to "the first to file", and they may have some preliminary stuff going. THis company has something very important if your description was accurate, other companies are busy patenting specific gene and gene sequences, but without specifying the function of these genes, these patents may not be that useful, this company is short cutting (by activating the genes without having to go through a lengthy process of replication) the route to discovering what each gene or actually combination of gene does or what the lack of such genes does, with good funding, they could get a library of these functions and potential applications quite rapidly. By the way, it was not a thousand patents it was, I believe a thousand genes (VBG and VBD). Zeev